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INTRODUCTION: Bladder cancers are not very common in the young population below 20 years of age,
especially in thosewhohavenotbeenexposed to chemotherapy, bladder augmentation surgery andother
known risk factors. By highlighting this case we hope to raise awareness in the medical community, that
the symptom of visible haematuria can potentially be due to a bladder malignancy and therefore this
should be thoroughly investigated.
PRESENTATIONOF CASE:An 18-year-old female presentedwith intermittentmacroscopic haematuria and
non-speciﬁc abdominal pain. Physical examination and routine blood tests were normal. An ultrasound
scan initially showed a bladder wall lesion, which a ﬂexible cystoscopy conﬁrmed. Histology revealed
grade 2 papillary transitional cell carcinoma of the bladder with no invasion into the lamina propria
(G2pTa TCCB).
DISCUSSION: We recognise through our literature review that paediatric bladder cancers are not com-
monly reported in the UK. In our paper we highlight the relevant major studies that have been carried
out world-wide, the reported incidence so far and gaps in the evidence base.
CONCLUSION: Despite the dearth of data about paediatric bladder malignancies there is enough case-
based evidence, from world-wide sources, to support that bladder cancer must be suspected in the
event of macroscopic haematuria. Ultrasound and cystoscopy are the standard diagnostic tools for blad-
der tumours. Endoscopic resection of the tumour followed up by interval ultrasound scans and ﬂexible
cystoscopy checks remain the mainstay of treatment hitherto.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Bladder cancer below the age of 20 years old is not only rare,
with an approximated total of 125 cases being collected worldwide
by 2010 [1] but it has also been deﬁned as clinico-pathologically
distinct from bladder tumours in older age groups [2]. The major-
ity are low grade superﬁcial transitional cell carcinomas and are
associated with a low rate of recurrence [3].
As benign causes of frank haematuria are more common in this
age group than tumours, this often leads to a considerable delay in
the diagnosis [2]. According to the literature, there are time delays
of up to 1 year or more from initial onset of symptoms to diagno-
sis, in more than a quarter of cases [2]. It is understandable that
clinicians have a low index of suspicion in this group of patients
when a study like that conducted by Greenﬁeld et al., showed that
only 3 children/young adults (all aged less than 20) out of 342
who presented with frank haematuria were eventually diagnosed
with bladder tumours [4]. There is also less inclination to expose
young people to a general anaesthestic to performa cystoscopy and
∗ Corresponding author. Tel.: +44 7768229626.
E-mail addresses: lisash33han@gmail.com,
lisash33han@doctors.org.uk (L. Sheehan).
possibly causing urethral trauma. However, this important diagno-
sis should not be missed or delayed and we would like to raise
clinicians’ index of suspicion for bladder cancer in the under age
20 group who present with haematuria and thus achieve the best
prognostic outcomes.
2. Case report
Our patient was a healthy Caucasian 18 year old female high
school student, who had never smoked, had not been exposed to
industrial chemicals and drank minor quantities of alcohol (5units
per week on average). Her only previous medical history was mild
asthma and a paraumbilical hernia repair aged 6. There was no
history of early onset cancers in the family. She was sexually active
at the time of the presentation and was a keen sportswoman, who
belonged to the local football team.
She presented to her general practitioner (GP) after having had
2 discreet episodes of visible haematuria over a 2 week period. She
also had some non-speciﬁc intermittent abdominal pains at the
time, which she had not likened to menstrual type period pain. Her
last menstrual period had been 3 weeks prior and there was no
history of dysuria or trauma.
Physical examination was unremarkable and a urine dipstick
showed no signs of infection, it was only positive for blood. The GP
http://dx.doi.org/10.1016/j.ijscr.2014.12.024
2210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1
Summary of the evidence.
Paper reference
number and year
No of cases Age of patient or age
range of patients
Symptoms Method of diagnosis/treatment Histopathology Follow up time and incidence
of recurrence/prognostic
information
[1] (2010) 6 <18 years/M:F =4:2 Haematuria, pyelonephritis Ultrasound,
cystoscopy/endoscopic
resection
G1 TCC
G1-G3 TCC
No recurrences (1.5–5 years)
mean 3.2
[3] (2010) 140 12–18
years/M:F =2:1
Haematuria Ultrasound,
cystoscopy/endoscopic
resection
Papillary urothelial neoplasm
of low malignant potential
(PUNLMP) =50.7%
Rhabdomyosarcoma=36.4
% 30 year study.
Conditional survival calculated
for 1 and 2 years after disease
diagnosis was 93.6% and 97.5%
5-year survival rates were
50–80% over 30 years
[16] (1989) 2 15–20 years Haematuria Unavailable Low grade TCC No recurrence
[17] (1992) 1 8 year, female Symptoms of appendicitis Ultrasound, endoscopic
resection
Grade 1 TCC No recurrence
[18] (2001) 5 13–20 years Frank haematuria and in the
women, also recurrent cystitis
Pelvis USS, urogram, urine
cytology and endoscopic
resection
Grade 1 TCC and papillomas No recurrence
Average 41 months follow up
1st year: urinary
cytology and cystoscopy every 3
months
2nd year: urinary cytology every 3
months and cystoscopy every 6
months in the 2nd year
3rd year: urinary cytology and bladder
ultrasound every 6 months and
cystoscopy every year.
In a 13-year-old patient- annual
cystoscopy check-up under general
anesthesia in the ﬁrst 3 years, and in
later year, urinary cytology and
bladder ultrasound every year.
[19] (1999) 1 19 years, male Frank haematuria and bladder
irritative symptoms
(frequency, dysuria and
urgency)
Incidental ﬁnding during
cystolithotomy
TCC, grade 2 with invasion of
lamina propria
Patient lost to follow up
[20] (2005) 23 4–20 years Frank painless haematuria Ultrasound,
cystoscopy/endoscopic
resection+mitomycin C
2 papilloma, 10 PUNLMP, 8 low
grade papillary urothelial
carcinoma (PUC), 3 high grade
PUC
0.5–13 years (mean
4.5)
0 recurrence
[21] (2014) 1 9, male Frank painless haematuria Ultrasound and CT
urogram/endoscopic resection
PUNLMP 16 months, no recurrence
[22] (1996) 5 11–18, all males Frank haematuria Ultrasound, urine cytology and
cystoscopy
Papilloma, 2 grade 1 TCCs, 2
grade 2 TCCs. Superﬁcial to
lamina propria
0.7–6 years (mean 3.5) 1
recurrence
[23] (2014) 1 16, female Frank haematuria Ultrasound and cytoscopy Low grade TCC Repeat TURBT after 2 months
revealed no persistent
abnormal cells
[24] (2014) 1 13 year old male Frank haematuria and
concomitant appendicitis
Ultrasound, CT and subsequent
endoscopic resection at the
time of appendicectomy
Mitomycin C.
papillary TCC, TaG1 stage No recurrence at 18 months
[25] (2014) 8 <18 years Haematuria Ultrasound and cystosocpy TCC. Two G1Ta, one G1T1, one
G2T1, and ﬁve G2Ta.
one patient had 2 small
tumours, the rest were single
lesions
8–27 years (mean 15 years). No
recurrences
[32] (2014) 1 16 year old male Painless frank haematuria Ultrasound, urine cytology and
cystoscpy
Low grade TCC, Ta 14 months, no recurrence
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sent the patient for a urinary tract ultrasound scan which reported
“an echodense polypous lesion present on the right side of the blad-
der wall measuring 21×15×17mm” and on receipt of this report,
was referred urgently for a Urology review. As is routine in the
NHS for suspected cancer, the patient was seen within 2 weeks of
referral by a urologist.
A microscopy and culture test of her urine conﬁrmed her urine
to be sterile and urine cytology was negative for aberrant cells.
An initial diagnostic ﬂexible cystoscopy showed a 2×2 cm raised
lesion and some surrounding erythematous patches nearby. A stag-
ingCTurogramshowednoevidenceof anyupper tract abnormality,
lymph nodes or metastases.
Rigid cystoscopy and transuretheral resection of the bladder
tumour were carried out soon after. The tumour was a unifo-
cal 2 cm×2 cm pedunculated bladder lesion, which was resected
down to muscle in its entirety. Additional random bladder biopsies
were also sent for histology.
Histology revealed grade 2 papillary transitional cell carcinoma
of the bladder with no invasion into the lamina propria (G2pTa
TCCB). It was conﬁrmed that the lesion was unifocal as all other
biopsies came back negative. After a multi-disciplinary discussion
of her case, she was subsequently treated with a course of intrav-
esical mitomycin C.
A relook ﬂexible cystoscopy at 3 and 6 months has shown no
signs of recurrence and she will continue to be followed up as an
outpatient in the regular surveillance programme. Genetic map-
ping has also not revealed any predisposing genetic factors.
To our knowledge this is the ﬁrst report of a British female in
the under 20s age group, who has been diagnosed with low grade
TCC and subsequently treated with intravesical mitomycin C.
3. Literature review
3.1. Method
Thepapers gathered for this literature reviewweregeneratedby
multiple database searches (Medline, Pubmed and EMBASE) using
the following keywords/terms: bladder, urothelial, transitional,
neoplasm, carcinoma, cancer, young, children, pediatric, child,
paediatric, childhood, adolescent, less than, under, 20, twenty,
teenage from 1946 to 2014. In order to be comprehensive, we also
reviewed the literature published or cited by well known medical
organisations such as the National Cancer Institute, the European
AssociationofUrologists (EAU), theBritishAssociationofUrological
Surgeons (BAUS) and the World Health Organisation (WHO).
We speciﬁcally wanted to look at papers that concentrated
on bladder cancers in the zero risk population group and in the
under 20s age group. In the literature search results, there were
a number of papers that have cited children having had previous
gastrointestinal augmentation cystoplasty as a risk factor for later
developing a bladder malignancy [5–7]. A higher incidence of blad-
der cancers has also been noted in children who have previously
received chemotherapy for tumours andhaematologicalmalignan-
cies [8,9]. Any case reports concerning patients with these known
predisposing factors for bladder cancer were also excluded as we
felt that this cohort of patients should be categorised as ‘high risk’
regardless.
There were no other search limits used or ﬁlters applied. Any
citations foundnot to be available in full paper format, either online
or in hard copy format, were excluded [10–14].
4. Results
In total the literature search produced a range of papers, ranging
from single case reports and case series to national epidemiolog-
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Table 2
Simpliﬁed WHO/ISUP 2004 histological classiﬁcation of urothelial tumuors (modiﬁed from [34]).
Noninvasive urothelial neoplasm Invasive urothelial carcinoma
Papillary type Non papillary type
Urothelial papilloma, including
inverted type
Urothelial carcinoma in situ
Papillary urothelial neoplasm
of low malignant potential
Low-grade papillary urothelial
carcinoma
High-grade papillary urothelial
carcinoma
ical case studies. A summary of the papers is collated in Table 1.
Most of the reported cases have come from large epidemiologi-
cal studies conducted in North America, such as the Surveillance,
Epidemiology and End Results (SEER) study [3] and from the
WHO/International Society of Urological Pathology (ISUP) consen-
sus classiﬁcation report [15].
The SEER program was a 30 year long data collection study that
included many contributing health facilities from all over North
America. The health facilities reported new cases of cancer to a
single database and the government run SEER program analysed
the data. The authors were able to determine incidence rates of
different histological bladder malignancies according to sex, age
group and race. Over a 30year period theyonly identiﬁed140 cases,
of which transitional cell carcinoma (TCC) was the most common
in the age group 12–18. There was a 2:1 male to female case ratio
[3].
With regard to theUK, there have only been a few sporadic cases
of bladder cancer reported and the male:female ratio seems to be
similar at ∼3:1 [1].
Most of the case studies found deﬁned their cohort of young
patients as being younger than 40 due to epidemiological reasons
but as it has become apparent with time that the under 20s age
group are clinico-pathological different from older patients, more
studies have started to collect data from this age group speciﬁcally.
Currently there is a lack of data regarding best treatment for these
patients and also follow up intervals and length of time.
5. Discussion
5.1. Aetiology
The aetiology of bladder cancer in the under 20s age group is
poorly understood. Although in the older age group, environmental
factors such as cigarette smoke, naphthalenedye, chemicals used in
the rubber industry, bladder stones and schistosomiasis have been
identiﬁed as signiﬁcant risk factors. However, these environmental
agents generally do not have much relevance to children and ado-
lescents. The inconsistency of environmental factors and the early
onset of the disease suggest that there is a genetic predisposition
in these patients but as yet paediatric bladder cancers have not
been found to be associated with aberrant genetic characteristics
[28–30]. It is also unclear as to why there is a male preponderance
for the disease.
5.1.1. Clinical presentation
Every case presented with frank haematuria and a small per-
centage of cases also reported abdominal pain [17,24,35] or
symptoms of irritative bladder [1,18,19,35]. Ultrasound has proven
to be a very sensitive test for picking up bladder tumours in young
people, unlike in the older age group, where it can be more unre-
liable [30]. Urine cytology did not aid the diagnosis in a single
reported case and this has been purported to be because most of
the cases are low grade [2]
5.1.2. Management
Management thereafter also appears to be quite uniform, with
almost all cases having a single diagnostic and curative bladder
tumour resection (Table 1). Partial cystectomies have only been
carried out in high grade cases [33,36] and where anatomically it
was reported to be difﬁcult for adequate endoscopic resection [33].
With regard to adjuvant chemotherapy however, there is a
lot of variation as to whether it is used and how it is admin-
istered. There is no evidence base about the use of intravesical
BCG in the under 20s age group as yet and the decision making
is based on the histopathology grading and staging of the bladder
cancer [20,24,33]. Only one paper has reported the use of MVAC
(Methotrexate, Vinblastine, Adriamycin and Cisplatin) [35]. As the
rates of recurrence seem to be so low in general, this supports the
current trend to hold off using adjuvant chemotherapy in this age
groupandavoid further invasive treatment and its side-effects [33].
However, the evidence regarding prognosis is currently too weak
for any solid recommendations to be made.
5.1.3. Prognosis and follow-up
The lack of detailed, consistent prognostic information also
makes it unclear as to how these patients should be followed up.
Clinicians want to avoid instrumenting a young bladder and caus-
ing more urethral trauma than is necessary but at the same time,
detect recurrences early. Most centres across the world seem to
use cystoscopy±ultrasound±urine cytology for followupbut none
have been brave enough to suggest when these patients can safely
stop being followed up. Reassuringly, the few long term follow up
studies that have been carried out show that recurrences are very
unusual in the under 20 years old group [1,2,17,20,25]. However, it
can be argued that vigilant follow up is required based on a small
proportion of cases that do get a recurrences, even in the low grade
TCC group [22,34,35]. Over the 30 year study period of the SEER
program, 5 year survival rates in these patients widely ranged from
50–80% [3]. Itwouldbeworthwhile repeating this study togetmore
concurrent results.
After analysing the literature, two apparent reasons for a lack of
prognostic information canbeoffered. Firstly, thehistopathological
reporting classiﬁcation system was last overhauled in 2004 by the
World Health Organisation (WHO) [3,26,27] (Table 2). Therefore,
even though the overwhelming majority of the literature report
that patients under the age of 20 usually present with low grade
superﬁcial bladder cancerswith no spread [2] the histopathological
minutiae have only really been agreed upon in the last decade. A
re-examination of the cases in the study conducted by Fine et al.
[20] has shown that 10 patients (44% of the cohort) who would
have been diagnosed with papillary urothelial carcinomas, using
the old system, were actually graded as PUNLMP. New long term
follow up studies are required, according to age of the patient and
the classiﬁcation of the tumour.
This brings us to the second reason, which is that up until
recently, what is considered a ‘young’ person diagnosed with blad-
der cancer has been ill-deﬁned. The majority of case studies have
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focussed on the under 40s group and the data from children and
adolescents has not been studied speciﬁcally. Now that it is becom-
ing apparent that the under-20s age group is clinico-pathologically
different from their older cohort [34], this information can be tar-
getted.
6. Conclusion
This case was investigated and treated smoothly without much
delaybut there ispotential forother cases tobemissedor theirdiag-
nosis to be delayed because clinicians have a low index of suspicion
in this age group. This case report and literature review highlights
the signiﬁcance of haematuria in the low risk paediatric group and
its association with bladder malignancies. Evidence so far shows
that the majority of cases are very treatable and have good long
term survival statistics butwe are lacking data tomake ﬁrm recom-
mendations as to the optimummanagement plan in the under-20’s
and their follow-up. In the UK and Europe, it would be prudent to
setup a large cancer registry to look at bladder cancer in the under
20s and have a standardised way of collecting and reporting the
data with these speciﬁc questions in mind.
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